215 related articles for article (PubMed ID: 29782654)
1. DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4.
Cannizzaro E; Bannister AJ; Han N; Alendar A; Kouzarides T
FEBS Lett; 2018 Jul; 592(13):2308-2322. PubMed ID: 29782654
[TBL] [Abstract][Full Text] [Related]
2. DDX3X functionally and physically interacts with Estrogen Receptor-alpha.
Pardeshi J; McCormack N; Gu L; Ryan CS; Schröder M
Biochim Biophys Acta Gene Regul Mech; 2022 Feb; 1865(2):194787. PubMed ID: 35121200
[TBL] [Abstract][Full Text] [Related]
3. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.
Yori JL; Seachrist DD; Johnson E; Lozada KL; Abdul-Karim FW; Chodosh LA; Schiemann WP; Keri RA
Neoplasia; 2011 Jul; 13(7):601-10. PubMed ID: 21750654
[TBL] [Abstract][Full Text] [Related]
5. Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.
Choi H; Kwon J; Cho MS; Sun Y; Zheng X; Wang J; Bouker KB; Casey JL; Atkins MB; Toretsky J; Han C
Cancer Res; 2021 Jul; 81(13):3607-3620. PubMed ID: 33941613
[TBL] [Abstract][Full Text] [Related]
6. KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.
Yao L; Hao Q; Wang M; Chen Y; Cao H; Zhang Q; Yu K; Jiang Y; Shao Z; Zhou X; Xu Y
Oncogene; 2023 Nov; 42(47):3514-3528. PubMed ID: 37845393
[TBL] [Abstract][Full Text] [Related]
7. Kruppel-like factor 4-dependent Staufen1-mediated mRNA decay regulates cortical neurogenesis.
Moon BS; Bai J; Cai M; Liu C; Shi J; Lu W
Nat Commun; 2018 Jan; 9(1):401. PubMed ID: 29374155
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A.
Ma Y; Shi Y; Li W; Sun A; Zang P; Zhang P
Cell Stress Chaperones; 2014 Mar; 19(2):217-26. PubMed ID: 23884787
[TBL] [Abstract][Full Text] [Related]
9. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression.
He H; Li S; Hong Y; Zou H; Chen H; Ding F; Wan Y; Liu Z
J Biol Chem; 2015 May; 290(21):13567-77. PubMed ID: 25851906
[TBL] [Abstract][Full Text] [Related]
11. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
12. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
[TBL] [Abstract][Full Text] [Related]
13. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.
Hu W; Hofstetter WL; Li H; Zhou Y; He Y; Pataer A; Wang L; Xie K; Swisher SG; Fang B
Clin Cancer Res; 2009 Sep; 15(18):5688-95. PubMed ID: 19737957
[TBL] [Abstract][Full Text] [Related]
14. MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.
Wang R; Yu W; Zhu T; Lin F; Hua C; Ru L; Guo P; Wan X; Xue G; Guo Z; Han S; Lv K; Zhang G; Ge H; Guo W; Xu L; Deng W
Cancer Sci; 2023 Jun; 114(6):2277-2292. PubMed ID: 36786527
[TBL] [Abstract][Full Text] [Related]
15. DDX3X Multifunctionally Modulates Tumor Progression and Serves as a Prognostic Indicator to Predict Cancer Outcomes.
Lin TC
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906196
[TBL] [Abstract][Full Text] [Related]
16. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
Zhang N; Su P; Li X; Xi J; Li X; Xu L
Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
18. Role of
Choi H; Roh J
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587813
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma.
Song E; Ma X; Li H; Zhang P; Ni D; Chen W; Gao Y; Fan Y; Pang H; Shi T; Ding Q; Wang B; Zhang Y; Zhang X
PLoS One; 2013; 8(7):e67758. PubMed ID: 23861801
[TBL] [Abstract][Full Text] [Related]
20. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
